Rolinsatamab
Product Specifications
CAS Number
2095467-30-2
Target
ADC Antibody, IL Receptor
Related Pathways
Immunology/Inflammation, Antibody-drug Conjugate/ADC Related
Purity
>95%
Bioactivity
Rolinsatamab is a fully humanized selective monoclonal antibody that is a potent dual inhibitor of IL-4 and IL-13. Rolinsatamab chimeric antigen receptor sequence T cells. Rolinsatamab can be used to prevent and treat immune diseases.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2030437-01 0.01 mg
Recombinant Cluster Of Differentiation (CD163)
Sign In for Pricing
View Details MBS2030437-02 0.05 mg
Recombinant Cluster Of Differentiation (CD163)
Sign In for Pricing
View Details MBS2030437-03 0.1 mg
Recombinant Cluster Of Differentiation (CD163)
Sign In for Pricing
View Details MBS2030437-04 0.2 mg
Recombinant Cluster Of Differentiation (CD163)
Sign In for Pricing
View Details MBS2030437-05 0.5 mg
Recombinant Cluster Of Differentiation (CD163)
Sign In for Pricing
View Details